<DOC>
	<DOCNO>NCT01812525</DOCNO>
	<brief_summary>Our study investigate inhalation therapy NaCl 3 % compare standard therapy inhalation treatment moderate severe bronchiolitis . The impact length hospital stay analyze .</brief_summary>
	<brief_title>Moderate Severe Bronchiolitis : Standard Therapy Versus Therapy With NaCl 3 % Inhalations</brief_title>
	<detailed_description>Acute viral bronchiolitis common low respiratory tract infection first year life lead large number hospital admission . The recommended treatment supportive . However many different type drug inhalation study efficacy remain controversial . Our study compare recommend supportive therapy supportive therapy combine hypertonic saline ( NaCl 3 % ) inhalation treatment moderate severe bronchiolitis . This first study use true control group inhalation .</detailed_description>
	<mesh_term>Bronchiolitis</mesh_term>
	<criteria>child age 6 week 24 month first episode wheeze diagnosis moderate severe bronchiolitis : The patient rank moderately severely ill accord Wang clinical severity score Children mild bronchiolitis ( Wang score &lt; 5 ) Children preexistent cardiac disease Children clinically significant chronic respiratory disease Immunocompromised child Children gestational age birth le 34 week Children receive immunoprophylaxis therapy ( i.e RSV immune globulin therapy ) Children receive corticosteroid form precede 2 week presentation Children receive bronchodilator within 24 hour presentation Children critical illness presentation require immediate admission intensive care unit</criteria>
	<gender>All</gender>
	<minimum_age>6 Weeks</minimum_age>
	<maximum_age>24 Months</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Bronchiolitis</keyword>
	<keyword>Moderate Severe</keyword>
	<keyword>Hypertonic saline</keyword>
	<keyword>NaCl 3 % inhalation</keyword>
	<keyword>Standard therapy</keyword>
	<keyword>Wang score</keyword>
	<keyword>in-patients</keyword>
</DOC>